| 2020 | 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39 + CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2020 | Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
| CANCER RESEARCH AND TREATMENT |
| 2020 | Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancer | SURGICAL ONCOLOGY-OXFORD |
| 2020 | Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2020 | Pelvic malakoplakia presenting as endometrial cancer: a case report
| Obstetrics & Gynecology Science |
| 2020 | Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching
| Obstetrics & Gynecology Science |
| 2020 | Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy | JOURNAL OF CLINICAL MEDICINE |
| 2020 | A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
| YONSEI MEDICAL JOURNAL |
| 2020 | Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
| BMC CANCER |
| 2020 | Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2020 | The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study
| BMC CANCER |
| 2020 | Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
| BMC CANCER |
| 2019 | Dose-Ranging Study of Ramosetron for the Prevention of Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Prospective Randomized Study
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | Asian Society of Gynecologic Oncology International Workshop 2018 | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2019 | Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy | EJSO |
| 2019 | Involved-field radiation therapy for selected cases of recurrent ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2019 | Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer
| Yonsei Medical Journal |
| 2019 | Preliminary Results From a Randomized Controlled Study for an App-Based Cognitive Behavioral Therapy Program for Depression and Anxiety in Cancer Patients
| Frontiers in Psychology |
| 2019 | Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
| Cancer Research and Treatment |
| 2019 | Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer | International Journal of Gynecological Cancer |
| 2019 | Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2019 | Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer
| CANCER MEDICINE |
| 2018 | Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
| YONSEI MEDICAL JOURNAL |
| 2018 | Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer | GYNECOLOGIC ONCOLOGY |
| 2018 | Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' Exons | Anticancer Research |
| 2018 | Periumbilical infiltration of lidocaine with epinephrine for postoperative pain reduction in single-port laparoscopic adnexal surgery | JOURNAL OF OBSTETRICS AND GYNAECOLOGY |
| 2018 | Diagnostic Value of 18F-FDG PET/CT and MRI in the Preoperative Evaluation of Uterine Carcinosarcoma | NUCLEAR MEDICINE AND MOLECULAR IMAGING |
| 2018 | Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer
| BMC CANCER |
| 2018 | Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas.
| Obstetrics & Gynecology Science |
| 2018 | Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer.
| Obstetrics & Gynecology Science |
| 2018 | In-bag power morcellation technique in single-port laparoscopic myomectomy
| Obstetrics & Gynecology Science |
| 2018 | Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer. | GYNECOLOGIC ONCOLOGY |
| 2018 | Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
| PLOS ONE |
| 2018 | Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score
| BMC CANCER |
| 2018 | Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer. | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
| 2018 | Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2018 | Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial | GYNECOLOGIC ONCOLOGY |
| 2018 | Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure | SURGICAL ONCOLOGY-OXFORD |
| 2018 | MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2018 | Transcatheter Arterial Embolization for Severe Secondary Hemorrhage after Hysterectomy | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
| 2018 | Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
| CANCER RESEARCH AND TREATMENT |
| 2018 | Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2
| CANCER RESEARCH AND TREATMENT |
| 2017 | Sentinel lymph node mapping with indocyanine green in vaginal cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy | BMC CANCER |
| 2017 | Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2017 | Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer
| ONCOTARGET |
| 2017 | Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines
| ONCOLOGY REPORTS |
| 2017 | Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas
| ONCOTARGET |
| 2017 | External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
http://orcid.org/0000-0002-8342-8701
(15727870600)
